Dissecting cellulitis of the scalp treated by tumour necrosis factor inhibitors: a case series

Laure Frechet; Eve Puzenat; Romain Charollais; Flora Dresco; Clémentine Carlet; Irène Gallais-Serezal; Charlée Nardin; François Aubin

doi:10.1684/ejd.2021.3969

Dissecting cellulitis of the scalp treated by tumour necrosis factor inhibitors: a case series

European Journal of Dermatology ◽

10.1684/ejd.2021.3969 ◽

2021 ◽

Vol 31 (1) ◽

pp. 81-85

Author(s):

Laure Frechet ◽

Eve Puzenat ◽

Romain Charollais ◽

Flora Dresco ◽

Clémentine Carlet ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Case Series ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Get full-text (via PubEx)

Faculty Opinions recommendation of The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1104777.560749 ◽

2008 ◽

Author(s):

Geoff Littlejohn

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Population Based Study ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Get full-text (via PubEx)

Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19

Biomedicine & Pharmacotherapy ◽

10.1016/j.biopha.2021.111785 ◽

2021 ◽

pp. 111785

Author(s):

Serena Patel ◽

Meenu Wadhwa

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inflammatory Diseases ◽

Therapeutic Use ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Get full-text (via PubEx)

Impact of persistence with tumour necrosis factor inhibitors on healthcare resource utilization and costs in chronic inflammatory joint diseases

British Journal of Clinical Pharmacology ◽

10.1111/bcp.14387 ◽

2020 ◽

Cited By ~ 1

Author(s):

Manon Belhassen ◽

Florence Tubach ◽

Christophe Hudry ◽

Macha Woronoff‐Lemsi ◽

Laurie Levy‐Bachelot ◽

...

Keyword(s):

Tumour Necrosis Factor ◽

Resource Utilization ◽

Tumour Necrosis ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Joint Diseases ◽

Inflammatory Joint Diseases ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Get full-text (via PubEx)

Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert Consensus

Rheumatology ◽

10.1093/rheumatology/key076 ◽

2018 ◽

Vol 57 (Supplement_7) ◽

pp. vii32-vii41

Author(s):

Alessandra Bortoluzzi ◽

Guido Valesini ◽

Salvatore D’Angelo ◽

Bruno Frediani ◽

Laura Bazzichi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Expert Consensus ◽

Tumour Necrosis Factor Inhibitors ◽

Disease Modifying ◽

Necrosis Factor

Get full-text (via PubEx)

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

Annals of the Rheumatic Diseases ◽

10.1136/ard.2010.149419 ◽

2011 ◽

Vol 70 (11) ◽

pp. 1895-1904 ◽

Cited By ~ 245

Author(s):

X. Mariette ◽

M. Matucci-Cerinic ◽

K. Pavelka ◽

P. Taylor ◽

R. van Vollenhoven ◽

...

Keyword(s):

Systematic Review ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Observational Studies ◽

Meta Analysis ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Get full-text (via PubEx)

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study

Arthritis Research & Therapy ◽

10.1186/ar4584 ◽

2014 ◽

Vol 16 (3) ◽

pp. R127 ◽

Cited By ~ 43

Author(s):

Lotta Ljung ◽

Johan Askling ◽

Solbritt Rantapää-Dahlqvist ◽

Lennart Jacobsson ◽

Keyword(s):

Rheumatoid Arthritis ◽

Acute Coronary Syndrome ◽

Cohort Study ◽

General Population ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Coronary Syndrome ◽

Tumour Necrosis Factor Inhibitors ◽

National Cohort ◽

Necrosis Factor

Get full-text (via PubEx)

AB0948 Tumour necrosis factor inhibitors and their impact on diabetes mellitus among patients with psoriatic arthritis

10.1136/annrheumdis-2018-eular.3550 ◽

2018 ◽

Author(s):

S. Mantravadi ◽

M. George ◽

A. Ogdie

Keyword(s):

Diabetes Mellitus ◽

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Get full-text (via PubEx)

Immunosuppressants/tumour necrosis factor inhibitors

Reactions Weekly ◽

10.2165/00128415-201213850-00085 ◽

2012 ◽

Vol &NA; (1385) ◽

pp. 24

Author(s):

&NA;

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Get full-text (via PubEx)

CP-082 Optimised use of tumour necrosis factor inhibitors in rheumatology

European Journal of Hospital Pharmacy ◽

10.1136/ejhpharm-2016-000875.82 ◽

2016 ◽

Vol 23 (Suppl 1) ◽

pp. A36.1-A36

Author(s):

M Perpinya ◽

D Malla ◽

L Mallart ◽

E De Puig

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Get full-text (via PubEx)

Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis

Pharmacological Research ◽

10.1016/j.phrs.2019.104507 ◽

2020 ◽

Vol 158 ◽

pp. 104507 ◽

Cited By ~ 2

Author(s):

Francesca Marino ◽

Valeria Nucera ◽

Elisabetta Gerratana ◽

Alessia Fiorenza ◽

Donatella Sangari ◽

...

Keyword(s):

Cancer Risk ◽

Tumour Necrosis Factor ◽

Inflammatory Arthritis ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Get full-text (via PubEx)